Association of mutations with morphological dysplasia in de novo acute myeloid leukemia without 2016 WHO Classification -
defined cytogenetic abnormalities
Not exact matches
Low risk was
defined as patients with the presence of inv (16) / t (16; 16) or t (8; 21)
cytogenetic features, NPM1 or CEBPA mutations, or MRD < 0.1 % post-induction I in those with no high - risk features.
Dr. Talkowski has performed seminal studies to introduce high - resolution genomics techniques to delineate the types of genetic variation that were classically
defined using
cytogenetic methods, which has discovered new classes of complex genomic variation in the human genome that are remarkably common yet otherwise cryptic to conventional technologies.